TIF’s official position regarding the case of the law suit against Novartis over the allaged kickbacks to Pharmacy firms. This does not constitute a matter that TIF or any other patient oriented organisation must or should get involved in, particularly in view of the potential damage that statements from patients themselves can cause on their peer patients who are under this drug treatment. TIF invites, in addition, the global medical community which is the sole responsible stakeholder for prescribing drugs in any country, to continue and strengthen its efforts towards having at the centre of its work, the patients’ health and safety.
TIF and every other national or regional patient-oriented organisation, should leave this matter in the hands of justice and continue to serve its mission and reason for existence which is to support their patients in as many ways as possible. Close monitoring of the outcome of such events, remains of course, part of our commitment towards patients’ safety but action and intervention should be made only where and when it is essential and only when we are in possession of full and undisputed information.
To see our officical position, click here.